Vipidia comprises alogliptin, a booster of DPP-4, being a diabetes type 2 medication. It has been shown to enhance glycaemic control in a synergistic effect by boosting incretin hormones that encourage the release of insulin and decreases glucose secretion in the liver. Vipidia is taken with diet and exercise, and at times, other anti-diabetes medications for improved glycemic control.
Enhanced Insulin Regulation: Promotes meal related insulin release and lowers glucagon levels leading to the control of blood sugar.
Weight-Neutral Therapy: As compared to other oral anti-diabetic agents, Vipidia does not lead to weight gain as a common side effect.
Once-Daily Dosage: Contributes to improved patient compliance due to the ease of use of once a day tablet.
Well-Tolerated: A low incidence of hypoglycemia when administered alone or in combination with other oral antidiabetic agents that are not insulin secretors.
Vipidia provides specific regulation of blood sugar level by improving the body’s ability to produce insulin. Its action is glucose dependent and, therefore, effective in preventing relapse to hypoglycemia in patients with type 2 diabetes. It is helpful for patients who require further glycaemic regulation with relatively minimal side effects.
Vipidia is ideal for:
Adults with Type 2 diabetes not adequately controlled with current oral antidiabetic medication.
It is for patients who cannot manage their blood glucose level with diet, exercise alone and using only one medication.
Patients seeking a single-occupant weight-agnostic medication.
Swallow Vipidia with water, at any time of the day without regard to meals, usually in a single dose.
Take this tablet with water, without chewing it.
They should avoid seizing any type of food and engaging in any type of exercises without consulting their doctor.
Some patients may feel that they do not need to take the medication every day, they should avoid this at all costs if they want the best outcome.
Possible Side Effects: Cold symptoms such as a headache or a runny nose or even stomach problems. Serious side effects are uncommon but may include pancreatitis; if abdominal pain is experienced, consult with the health care provider.
Precautions: Should not be used in patients with Type 1 diabetes or diabetic ketoacidosis. If you have kidney or liver disease, consult your doctor before taking the medication.
Monitoring: Patients need to have their blood glucose levels checked frequently and require occasional cheque-ups to review the course of action.
Active Ingredient: Alogliptin
Formulation: Oral tablet
Dosage Strengths: Typically available in 12.5mg or 25mg
Frequency: Once daily
Better managing of Type 2 diabetes: Vipidia (Alogliptin) Tablets. Helping to maintain blood sugar levels and to keep to a strict regimen, Vipidia can assist in your journey towards a healthier lifestyle. Before you consider using Vipidia as part of your diabetes treatment, consult your physician.
Note: Always use Vipidia under medical supervision and follow your healthcare provider’s instructions for safe and effective use.